机译:DNA甲基化生物标志物候选物可用于结肠癌的早期检测
Department of Surgery The Johns Hopkins University School of Medicine Baltimore MD 21231 USA;
Department of Surgery The Johns Hopkins University School of Medicine Baltimore MD 21231 USA;
Department of Pathology The Johns Hopkins University School of Medicine Baltimore MD 21231 USA;
Department of Molecular Biology Sapporo Medical University Sapporo Japan;
Department of Molecular Biology Sapporo Medical University Sapporo Japan;
Department of Pharmacy College of Pharmacy Gacheon University of Medicine and Science Incheon South Korea;
Department of Surgery The Johns Hopkins University School of Medicine Baltimore MD 21231 USA;
DNA hypermethylation; Biomarker; Early detection; Colorectal Cancer (CRC); FBN2; TCERGIL;
机译:DNA甲基化生物标志物候选物可用于结肠癌的早期检测。
机译:粪便和血液的DNA甲基化生物标记物用于结肠癌的早期检测
机译:前列腺癌的DNA甲基化生物标志物:候选人的确认和证据尿液是非侵入性检测中最敏感的体液。
机译:循环无细胞的DNA基QMSP证明了Sydecan2甲基化作为有望的表观遗传生物标志物,用于早期检测患癌前和癌细胞病患者的患者
机译:基于DNA甲基化的生物标记物的开发,用于早期检测鳞状细胞肺癌
机译:DNA甲基化生物标志物候选物可用于结肠癌的早期检测
机译:基于DNA-甲基化的泌尿外癌检测尿液:生物标志物概述及对生物标志物设计的考虑,DNA来源,以及检测技术